🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Genasense® is currently administered to subjects in clinical studies as a m...
Status
Completed
Location
Clinical Research Institute for Drug Development
Start Date
2005-12
Trial ID
NCT00543231
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different...
Status
Completed
Location
Kaiser Franz Josef Hospital
Start Date
2004-04
Trial ID
NCT00085228
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Genta Incorporated
Start Date
2000-12
Trial ID
NCT00017602
Treatments Being Tested
This non-randomized study will test the safety and effectiveness of Genasen...
Status
Completed
Location
Long Island Jewish Medical Center
Start Date
2001-01
Trial ID
NCT00021749
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as dacarbazine, use different w...
Status
Unknown
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
2003-08
Trial ID
NCT00070343
Treatments Being Tested
The treatment combination of Rituxan® (rituximab) and fludarabine has previ...
Status
Completed
Location
Georgetown University Medical Center/Lombardi Cancer Center
Start Date
2003-11
Trial ID
NCT00078234
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2000-04
Trial ID
NCT00005032
Treatments Being Tested
Phase I trial to study the effectiveness of combining carboplatin and pacli...
Status
Completed
Location
University of Wisconsin Hospital and Clinics
Start Date
2002-10
Trial ID
NCT00054548
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Genta Incorporated
Start Date
2001-07
Trial ID
NCT00024440
Treatments Being Tested
This randomized phase II trial is studying rituximab and combination chemot...
Status
Terminated
Location
Southwest Oncology Group
Start Date
2004-03
Trial ID
NCT00080847